David Pascoe
David Pascoe started the Rosacea Support Group in October 1998.

Promoted as being safer than systemic antibiotics, a 3% formulation of topical minocycline gel has passed Phase 2 clinical trials and is readying to commence Phase 3 trials. The owners of the product, currently named HY-01 – Hovione are promoting their in-development topical as more moisturising than other comparable topicals, and less likely to induce […]

Galderma has announced that they have received approval for Aklief cream (trifarotene 0.0005%) for the topical treatment of facial and body acne. It is being touted as the first new retinoid for acne in 20 years. Aklief for Rosacea? There is currently no information available on whether Aklief will be suitable for rosacea sufferers. Often […]

Having been sold just 1 year ago to Aclaris, the topical redness treatment for rosacea, Rhofade has again changed hands – this time to EPI Health. The value of the transaction is around $55m. Rhofade was previously owned by Allergan. What is Rhofade? Rhofade is Oxymetazoline HCL 1% Cream for the Redness of Rosacea. Officially […]

The benzoyl peroxide based Epsolay is one step closer to becoming a new treatment for the papules and pustules of rosacea. Based on an active ingredient of 5% bezoyl peroxide, and encapsulating inside silica, the new cream has continued to be tested and now Phase 3 results have been published. So what do the Phase […]